It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Long-term decline in lung function is generally considered to be progressive in individuals with established chronic obstructive pulmonary disease (COPD), despite the presence of intersubject variation. We hypothesized that the annualized rate of decline in forced expiratory volume in 1 second (FEV1) would not be constant among different time periods in the natural history of established COPD. We compared the annual change rates in FEV1 during the first 5 years and the last 5 years, estimated separately using a linear mixed-effects model in 10-year survivors (n = 110). The subjects were classified into three FEV1 decline groups, based on the 25th and 75th percentile values in each time period. The rates of FEV1 changes, calculated from the first 5 years and the last 5 years, did not correlate with each other among 10-year survivors; the subjects of each FEV1 decline group during the first 5 years did not consistently remain in the same FEV1 decline group during the last 5 years. Smoking status and exacerbation frequency were not associated with decline in FEV1. In conclusion, the disease activity, which is often expressed as annualized change in FEV1, might be changeable either way over years in patients with established COPD.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Hokkaido University, Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Sapporo, Japan (GRID:grid.39158.36) (ISNI:0000 0001 2173 7691)
2 Hokkaido University, Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Sapporo, Japan (GRID:grid.39158.36) (ISNI:0000 0001 2173 7691); JCHO Hokkaido Hospital, Center for Respiratory Diseases, Sapporo, Japan (GRID:grid.414280.b)
3 JCHO Hokkaido Hospital, Center for Respiratory Diseases, Sapporo, Japan (GRID:grid.414280.b)
4 KKR Sapporo Medical Center, Department of Internal Medicine, Sapporo, Japan (GRID:grid.417164.1) (ISNI:0000 0004 1771 5774)
5 Hokkaido Chuo Rosai Hospital, Department of Internal Medicine, Iwamizawa, Japan (GRID:grid.417164.1)
6 Otaru Kyokai Hospital, Department of Respiratory Medicine, Otaru, Japan (GRID:grid.417164.1)